241 related articles for article (PubMed ID: 4385551)
41. [Medical principles for the ambulatory treatment using tranquilizing agents].
Ernst K
Schweiz Rundsch Med Prax; 1973 Feb; 62(9):238-45. PubMed ID: 4690790
[No Abstract] [Full Text] [Related]
42. [Harmful effects of common drugs on the visual apparatus. Psychotropic drugs].
Hermans G
Bull Soc Belge Ophtalmol; 1972; 160(1):15-85. PubMed ID: 4403051
[No Abstract] [Full Text] [Related]
43. [Should we use one or several drugs in the treatment of mental disorders?].
Sirnes TB
Tidsskr Nor Laegeforen; 1974 Nov; 94(31):2175-8. PubMed ID: 4428480
[No Abstract] [Full Text] [Related]
44. [The customary drugs in the therapy of mental illness in France].
Ginestet D; Deniker P
Nervenarzt; 1967 Sep; 38(9):400-3. PubMed ID: 6052766
[No Abstract] [Full Text] [Related]
45. [Road safety under psychiatric drug targeting].
Brunnauer A; Laux G
Fortschr Neurol Psychiatr; 2008 Jun; 76(6):366-77. PubMed ID: 18512188
[No Abstract] [Full Text] [Related]
46. [Therapy of geriatric patients using analgetics, hypnotics psychotropic drugs and geriatrics].
Kanowski S
Internist (Berl); 1972 May; 13(5):187-96. PubMed ID: 4403071
[No Abstract] [Full Text] [Related]
47. [Medazepam. A new tranquilizer: simple test, intraindividual comparisons and combination therapy].
Spiegelberg U; Petrilowitsch N; Betz B
Arzneimittelforschung; 1968 Dec; 18(12):1559-63. PubMed ID: 5756249
[No Abstract] [Full Text] [Related]
48. [Advantages and disadvantages of psychopharmaceuticals].
Hippius H
Munch Med Wochenschr; 1966 Jul; 108(28):1438. PubMed ID: 6014563
[No Abstract] [Full Text] [Related]
49. Pharmacology of the central nervous system.
Shellenberger MK; Walaszek E
Prog Neurol Psychiatry; 1970; 25():106-29. PubMed ID: 4395104
[No Abstract] [Full Text] [Related]
50. [Biochemistry and psychiatry].
Bickel MH
Schweiz Med Wochenschr; 1967 Sep; 97(36):1167-73. PubMed ID: 4385790
[No Abstract] [Full Text] [Related]
51. [Psychopharmacologic agents and mictition disorders. Cystometric studies].
Ritter G; Grabner F
Nervenarzt; 1970 May; 41(5):232-4. PubMed ID: 5426750
[No Abstract] [Full Text] [Related]
52. [Understanding psychotropic drugs for nurses].
Mao CL
Hu Li Za Zhi; 1979 Jan; 26(1):66-74. PubMed ID: 256968
[No Abstract] [Full Text] [Related]
53. [Hazards in psychopharmacological treatment and their prevention].
Thiele W
Hippokrates; 1969 Apr; 40(8):302-7. PubMed ID: 5795574
[No Abstract] [Full Text] [Related]
54. [Formal genesis of psychoses].
Daun H
Fortschr Neurol Psychiatr Grenzgeb; 1973 Jan; 41(1):1-52. PubMed ID: 4486571
[No Abstract] [Full Text] [Related]
55. [Apropos of secondary psychic effects produced by psychotropic agents].
Cazzullo CL; Giannelli A
Encephale; 1967; 56(6):530-40. PubMed ID: 5613906
[No Abstract] [Full Text] [Related]
56. [Incidents and accidents during therapy with long-acting neuroleptics].
Escande M; Vasquez Villareal S; Gayral L
Ann Med Psychol (Paris); 1974 Jan; 1(1):112-20. PubMed ID: 4210849
[No Abstract] [Full Text] [Related]
57. [Psychotherapeutic agents: their use and abuse].
Pöldinger W
Hippokrates; 1968 Jul; 39(14):524-33. PubMed ID: 5730669
[No Abstract] [Full Text] [Related]
58. Some problems of classification of psychiatric disorders in relation to the use of psychotropic drugs.
Avrutsky GJ
Int J Neurol; 1967; 6(1):11-8. PubMed ID: 4392240
[No Abstract] [Full Text] [Related]
59. Endocrine effects of psychotropic drugs. 3. Glucose metabolism.
Shader RI; Belfer ML; DiMascio A
Conn Med; 1968 May; 32(5):389-94. PubMed ID: 5653076
[No Abstract] [Full Text] [Related]
60. Care-induced psychoses.
Rynearson RR
Tex Med; 1970 Jan; 66(1):58-60. PubMed ID: 5412215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
